CRP and peripheral arterial disease: In patients with severe PAD, statin therapy has been associated with a significant improvement in survival in cases with intense inflammatory activity, as measured by high-sensitivity CRP levels, but did not provide benefits in those with low inflammatory activity, suggesting that statins exert their protective effect through anti-inflammatory mechanisms or by attenuating the deleterious effects of inflammation (92).